Endogenous erythropoietin and the association with inflammation and mortality in diabetic chronic kidney disease.
Anemia and inflammation are prevalent in diabetic patients with chronic kidney disease (CKD). The role of endogenous erythropoietin (EPO) in the pathophysiology of anemia in chronic diseases and its relationship to clinical outcomes remain uncertain. In this cohort study, we aimed to identify factors associated with endogenous EPO levels and investigate their relation to all-cause mortality.
Version: za2963e q8za9 q8zb9 q8zcf q8zd0 q8ze5 q8zf9 q8zg3